IPSC

1.16511.74%
DE

Daphne E. Quimi

Independent Director

Ms. Daphne E. Quimi, M.B.A. CPA has been an Independent Director of Century Therapeutics, Inc. since September 2022. She is Independent Non-Executive Director of Chiesi Farmaceutici S.p.A. from January 2025. She had been Chief Financial Officer of Amicus Therapeutics, Inc. since January 1, 2019 until August 21, 2023 and served as its Senior VP of Finance Since August 21, 2023 until December 31, 2023. Ms. Quimi serves as Independent Director at Amylyx Pharmaceuticals, Inc. since June 2021. Ms. Quimi served as Senior Vice President of Corporate Affairs at Amicus Therapeutics, Inc. since June 2018 until January 1, 2019. Ms. Quimi served as Senior Vice President of Finance and Administration of Amicus Therapeutics, Inc. until 2018 and was Corporate Controller since October 7, 2010. Ms. Quimi served as Vice President of Finance at Amicus Therapeutics, Inc since December 2013. She served as Principal Financial Officer and Treasurer of Amicus Therapeutics from February 2011 to April 16, 2012. She served as Assistant Treasurer of Amicus Therapeutics until February 2011. Ms. Quimi joined Amicus Therapeutics in September 2007 as Director of Accounting Policy and External Reporting and previously served as Corporate Controller since January 2010. From October 2005 to September 2007, she worked at Bristol Myers Squibb where she served as Director of Consolidations and External Reporting. She also held roles of increasing responsibility in the finance department at Johnson & Johnson from May 1999 until July 2004. She served as an auditor at KPMG. Ms. Quimi has extensive experience in public accounting and financial reporting. She is a certified public accountant in New Jersey and a member of the American Institute of Certified Public Accountants and the Institute of Management Accountants. Ms. Quimi holds a BS in Accounting from Monmouth University, USA, which she received in 1988. She later earned a CPA, in New Jersey, USA. She concluded her studies with an MBA in Finance and International Business from New York University, USA in 1999. She is a US citizen.

Positions